/Investor DB

PMV — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Animabanimab.comOct 2020

Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.

AgTechBiotechDeep TechHealthtechGhent, BE

Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in

Co-investorsAgri Investment FundSeventure PartnersQbic FundV-Bio VenturesAIFVIB

eTheRNA Immunotherapiesetherna.beJun 2020

Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.

BiotechDeep TechMedical DevicesNiel, BE

Co-investorsFund+Boehringer Ingelheim Venture FundEQT Life SciencesNovalis LifeSciencesOmega FundsPWV

Theo Technologiestheoplayer.comJan 2020Acquired

Belgian video technology company behind THEOplayer and THEOlive, acquired by Dolby in 2024.

Co-investorsiThink VCSmartFin

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.